| Literature DB >> 32548131 |
Zheng Wang1, Yunjia Shi1, Yu Wang1,2, Lili Zhao2, Xingyang Cui1, Shanshan Wen1, Hanghang Liu1, Wen Cui1,3, Hongyan Chen2, Junwei Ge1,3.
Abstract
Canine circovirus (CanineCV), a new pathogen, was found to be associated with canine hemorrhagic diarrhea, vasculitis, granulomatous lymphadenitis, and acute gastroenteritis. Although CanineCV was highly positive rate in diarrhea cases, its pathogenicity remains controversial. In this study, the seroprevalence and associated risk factors of CanineCV infection among domestic dogs in northeastern China was investigated by an indirect enzyme-linked immunosorbent assay (iELISA) based on recombinant capsid protein. Results revealed the proposed iELISA had no cross-reactivity with other related pathogens, and yielded good diagnostic values. Then, to evaluate the rCap iELISA, this study applied it to detect antibodies against CanineCV in 1,047 clinical serum samples obtained from northeastern China in 2016-2017. Results showed the positive rates in the five cities of Jilin, Liaoning, and Heilongjiang provinces ranged from 22.22 to 42.29%. Statistical analysis shows a significant difference in age between dogs <3 months old with respect to the >1-year-old dogs (p = 0.005), that is, the CanineCV infection was more frequently identified from older dogs. In the artificially infected experiment, the dogs developed seroconversion after 9 or 12 days and the main way of virus excretion was through feces. More interestingly, among the 32 ELISA-positive serum samples, 34.75% samples tested positive for the CanineCV DNA by qPCR, far higher than that in ELISA-negative serum samples (5.26%, 2/38). This report is the first to demonstrate that CanineCV infection is common in the dog population in northeastern China. The results showed obvious differences in the positive rate associated with diarrhea, age, but not with different cities. This study also provide basis for evaluating the pathogenic potential of CanineCV. But, the pathogenicity, the relationship between antibody level and immune protection, and the harmful effects of this virus remain to be established.Entities:
Keywords: canine circovirus; capsid protein; indirect ELISA; pathogenicity; serological detection
Year: 2020 PMID: 32548131 PMCID: PMC7270207 DOI: 10.3389/fvets.2020.00294
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1Expression and identification of the rCap fusion protein. (A) SDS-PAGE analysis: Lane M, protein molecular weight marker; Lane 1, Rosetta control; Lane 2, pET-32a vector control; Lane 3, pET-32a-cap bacterial lysate; Lane 4, supernatant from pET-32a-cap bacterial lysate; Lane 5, the pellet of pET-32a-cap bacterial lysate; Lane 6, purified fusion protein. (B) Western blot analysis: Lane M, protein molecular weight marker; Lane 1, pET-32a vector control; Lane 2, pET-32a-cap bacterial lysate; Lane 3, purified fusion protein.
Figure 2Results of cross test of Western blot was performed with canine adenovirus type 2 positive sera (anti-CAV2), canine parvovirus positive sera (anti-CPV2), rabies virus positive sera (anti-RV), canine distemper virus positive sera (anti-CDV), and CanineCV negative sera control (NC). Lane M, protein molecular weight marker; Lane 1, pET-32a vector control; Lane 2, purified protein rCap.
Ratio of CanineCV-positive serum to CanineCV-negative serum for the optimization of assay conditions for the ELISA against recombinant rCap antigen.
| 1:25(+) | 2.748 | 2.589 | 2.512 | 2.465 | 2.336 | 1.998 |
| 1:25(–) | 0.121 | 0.109 | 0.112 | 0.125 | 0.132 | 0.141 |
| 1:50(+) | 2.640 | 2.558 | 2.293 | 2.223 | 1.964 | 1.926 |
| 1:50(–) | 0.110 | 0.109 | 0.145 | 0.165 | 0.2 | 0.251 |
| 1:100(+) | 1.551 | 1.402 | 1.384 | 1.641 | 2.185 | |
| 1:100(–) | 0.199 | 0.196 | 0.152 | 0.15 | 0.122 | |
| 1:200(+) | 1.876 | 1.763 | 1.753 | 1.649 | 1.583 | 1.674 |
| 1:200(–) | 0.071 | 0.076 | 0.082 | 0.104 | 0.118 | 0.123 |
| 1:400(+) | 1.696 | 1.781 | 1.798 | 1.891 | 1.921 | 1.849 |
| 1:400(–) | 0.089 | 0.110 | 0.111 | 0.097 | 0.109 | 0.093 |
Optimum values with the best positive-to-negative ratio are highlighted.
Results of cross reaction test of direct ELISA.
| DogCV(+) | 1.369 ± 0.025 |
| DogCV(–) | 0.099 ± 0.012 |
| Blank control | 0.074 ± 0.007 |
| Rabies virus | 0.100 ± 0.013 |
| Canine parvovirus 2 | 0.118 ± 0.009 |
| Canine distemper virus | 0.098 ± 0.018 |
| Canine adenovirus type 2 | 0.109 ± 0.014 |
| 0.089 ± 0.037 | |
| 0.019 ± 0.01 |
The serum showed positive or negative by Western blot.
All samples and controls were repeated 3 times.
Repeatability and reproducibility analysis of indirect ELISA.
| 1 | 1.613 | 1.51 | 1.502 | 1.541 | 0.061 | 4.02 | 1.261 | 1.300 | 1.197 | 1.252 | 0.052 | 4.15 |
| 2 | 1.074 | 0.996 | 0.970 | 1.013 | 0.054 | 5.34 | 1.156 | 1.002 | 0.989 | 1.049 | 0.093 | 8.86 |
| 3 | 0.879 | 0.907 | 0.815 | 0.867 | 0.047 | 5.44 | 0.991 | 0.899 | 0.881 | 0.924 | 0.059 | 6.39 |
| 4 | 0.073 | 0.068 | 0.073 | 0.071 | 0.002 | 4.04 | 0.078 | 0.069 | 0.081 | 0.076 | 0.006 | 8.22 |
| 5 | 0.058 | 0.06 | 0.061 | 0.059 | 0.001 | 2.56 | 0.059 | 0.058 | 0.064 | 0.061 | 0.003 | 5.33 |
| 6 | 0.100 | 0.101 | 0.100 | 0.100 | 0.0005 | 0.56 | 0.096 | 0.101 | 0.084 | 0.094 | 0.008 | 9.32 |
Comparison of the ELISA and Western blot test.
| Positive | 50 | 5 | 55 |
| Negative | 9 | 79 | 88 |
| Total | 59 | 84 | 143 |
| Total (% coincidence) | 84.75 (50/59) | 94.05 (79/84) | 90.21 (129/143) |
Summary of the CanineCV results of the sera tested by iELISA.
| 1 | Sera from laboratory animal center | 0/8 | 0 | – |
| 2 | Sera from cesarean section fetus dog | 0/3 | 0 | – |
| 3 | Location | 0.367 | ||
| Sera collected from Shengyang City | 41/97 | 42.27% | ||
| Sera collected from Daqing City | 25/65 | 38.46% | ||
| Sera collected from Harbin City | 225/532 | 42.29% | ||
| Sera collected from Changchun City | 4/18 | 22.22% | ||
| Sera collected from Mudanjiang City | 12/47 | 25.53% | ||
| 4 | Sera collected from Animal Teaching Hospital | |||
| Status | 0.007 | |||
| Sera from dogs without diarrheic disease in the past half year | 9/39 | 23.08% | ||
| Sera from dogs Suffered diarrheic disease in the past half year | 54/118 | 45.76% | ||
| Age | 0.016 | |||
| Sera from young pups <3 months old | 11/42 | 26.19% | ||
| Sera from >1-year-old dogs | 36/78 | 46.15% | ||
| Overall rate | 417/1,047 | 39.82% |
Figure 3The positive rate of CanineCV antibody every month from May 2016 to April 2017.
Figure 4Anti-CanineCV antibody titers in positive and negative canine serum samples. Positive and negative canine serum samples were prepared in dilutions of 1:100, 1:200, 1:400, 1:800, 1:1,600, and 1:3,200 used in an ELISA assay. The cutoff was determined by counting the mean OD value of the ELISA negative samples plus 3 standard deviation (SD).
Detection of the CanineCV DNA by qPCR in the experimental infection.
| Infection | Oral | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nasal | 0 | 0 | 0 | 0 | 0 | 1([2.75 ± 0.92] ×106) | 0 | 0 | 0 | |
| Fecal | 0 | 0 | 0 | 1 ([5.75 ± 1.84] ×106) | 2 ([3.62 ± 1.45] ×106) | 3 ([4.27 ± 1.68] ×107) | 3 ([5.42 ± 1.62] ×108) | 3 ([7.26 ± 1.98] ×107) | 3 ([3.41 ± 2.85] ×107) | |
| Control | Oral | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nasal | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Fecal | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
The detection result of the No.1 dog in the infected group.
The detection result of the No.2 dog in the infected group.
The detection result of the No.3 dog in the infected group.
Figure 5The antibody production of CanineCV in artificially experimental infected cases.